Sonic Healthcare Limited (SHL.AX) Stock Analysis & Winston Score
Sonic Healthcare is an Australian company that runs medical laboratories and radiology clinics. When a doctor needs to test a patient's blood, check an X-ray, or diagnose a disease, they send the work to companies like Sonic. Sonic is one of the largest pathology and diagnostic imaging providers in the world, serving patients, hospitals, and doctors across multiple continents. Sonic makes money by charging fees for each test or scan it performs, with payments coming from government health programs, private insurers, and patients directly. It operates mainly in Australia, Germany, the United States, the United Kingdom, and Switzerland, generating roughly $8–9 billion in annual revenue. Its scale and long-standing relationships with referring doctors create a meaningful competitive advantage, since switching costs in laboratory services are high. The key risk is that a large portion of past revenue came from COVID-19 PCR testing, which has now largely disappeared, putting pressure on the company to grow its base diagnostic business to fill that gap.
Winston Score: 51/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (11/30)
- Growth: Mixed (9/20)
- Cash Flow: Strong (8/10)
- Stability: Strong (7/10)
- Valuation: Mixed (4/10)
- Ownership: Good (8/15)
Key Facts
Price: 21.08 AUD
Market Cap: 10.4B AUD
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: Australian Securities Exchange

